Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PBP World MeetingPBP World Meeting
Not Confirmed
Not Confirmed
23-26 March, 2026
Not Confirmed
Not Confirmed
23-24 March, 2026
European Pharma Congre...European Pharma Congress
Not Confirmed
Not Confirmed
23-24 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PBP World MeetingPBP World Meeting
Industry Trade Show
Not Confirmed
23-26 March, 2026
Industry Trade Show
Not Confirmed
23-24 March, 2026
European Pharma Congre...European Pharma Congress
Industry Trade Show
Not Confirmed
23-24 March, 2026
Digital content

11 Mar 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-03-11/neurogene-to-participate-in-stifel-2026-virtual-cns-forum

03 Mar 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260303056424/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

26 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260226883579/en/Neurogene-Announces-FDA-Breakthrough-Therapy-Designation-for-NGN-401-Gene-Therapy-for-Rett-Syndrome

05 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260205890359/en/Neurogene-to-Participate-in-Upcoming-Investor-Conferences

04 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260204466670/en/Neurogene-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4

12 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260112556591/en/Neurogene-Announces-Recent-Achievements-and-Anticipated-2026-Key-Milestones-for-NGN-401-a-Potential-Best-in-Class-Gene-Therapy-for-Rett-Syndrome
ABOUT THIS PAGE